Loading provider…
Loading provider…
Vascular Surgery Physician in Orange, CA
NPI: 1740487347Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
Regents of the University of California
health.ucsd.edu
HQ Phone
Get M.D. Isabella's Phone Numberphone_androidMobile
Get M.D. Isabella's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2026

American Board of Surgery
Surgery

American Board of Surgery
Vascular Surgery
Loma Linda University Health Education Consortium
Fellowship • Vascular Surgery - Independent
2012 - 2014
Residency • Surgery
2007 - 2012
UNR Med
med.unr.edu
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 147 | 228 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 70 | 70 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 49 | 59 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 43 | 69 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 40 | 44 |
Evolving Utility of Endovascular Treatment of Juxtarenal, Pararenal, and Suprarenal Abdominal Aortic Aneurysms Associated With Increased Risk of Mortality Over Time.
Authors: Roy Fujitani, Nii-Kabu Kabutey
Publication Date: 2020-02-10
Authors: Roy Fujitani, Anthony Chau, Carlos Donayre, Nii-Kabu Kabutey, William Duong
Journal: Ann Vasc Surg
Publication Date: 2021-10-12
Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
Authors: Roy Fujitani, Matthew Whealon, Samuel Chen
Publication Date: 2016-10-30
Lead Sponsor: Pluristem Ltd.
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: PLX-PAD